RNA breakthroughs, Case Studies and Partnerships
September 10-11, 2025Boston Exhibition & Convention Center, USA Mikko Turunen, PhDFounder and CSO at RNatives Inc.Speaker
Profile
Dr. Mikko Turunen is a seasoned expert in gene therapy with over 27 years of experience. Throughout his career, his research focus has been non-coding RNAs, cardiovascular disease, and gene delivery to animals. In 2009, he made a pioneering discovery by being the first to demonstrate transcriptional gene activation by small RNAs in vivo. Dr. Turunen is also the founder of RNatives, where his groundbreaking work on RNA activation is now advancing the field of RNA-based medicine
Agenda Sessions
miR-466 Mediated VEGFA Upregulation for Heart Failure and Peripheral Artery Disease Treatment
, 12:05pmView Session